Clinical Site

Chicago, Illinois 60641

2 studies enrolling now · 14 studies all time

What they study most

Bipolar Depression, Bipolar Disorder, Manic, C3 Glomerulopathy (C3G), Celiac Disease, Diabetes Mellitus, Type 2, Fatty Liver, Nonalcoholic, Generalized Anxiety Disorder, Hidradenitis Suppurativa, Hypertriglyceridemia, NAFLD, Respiratory Syncytial Virus Infections, Schizophrenia

Studies at this site

• A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia — Recruiting now
• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study of Lumateperone in the Treatment of Patients With Bipolar Mania — Completed
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia — Completed
• An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN) — Running, not enrolling
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• PRV-015 in Gluten-free Diet Non-responsive Celiac Disease — Completed
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
• Lumateperone for the Prevention of Relapse in Patients With Schizophrenia — Completed
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression — Completed
• Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally — Completed
• Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease — Completed
• Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed
• Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed